Citations (293)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Chuong Pham, Swati Nagar & Ken Korzekwa. (2020) Numerical analysis of time-dependent inhibition kinetics: comparison between rat liver microsomes and rat hepatocyte data for mechanistic model fitting. Xenobiotica 50:11, pages 1301-1310.
Read now
Read now
Lianne J. Stevens, Joanne M. Donkers, Jeroen Dubbeld, Wouter H. J. Vaes, Catherijne A. J. Knibbe, Ian P. J. Alwayn & Evita van de Steeg. (2020) Towards human ex vivo organ perfusion models to elucidate drug pharmacokinetics in health and disease. Drug Metabolism Reviews 52:3, pages 438-454.
Read now
Read now
Ravindra V. Alluri, Rui Li & Manthena V. S. Varma. (2020) Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?. Expert Opinion on Drug Metabolism & Toxicology 16:5, pages 387-401.
Read now
Read now
Shinji Iwasaki, Yohei Kosugi, Andy Z.X. Zhu, Sayaka Nakagawa, Noriyasu Sano, Miyuki Funami, Mai Kosaka, Atsutoshi Furuta, Hideki Hirabayashi & Nobuyuki Amano. (2019) Application of unbound liver-to-plasma concentration ratio to quantitative projection of cytochrome P450-mediated drug–drug interactions using physiologically based pharmacokinetic modelling approach. Xenobiotica 49:11, pages 1251-1259.
Read now
Read now
Neel Deferm, Tom De Vocht, Bing Qi, Pieter Van Brantegem, Eva Gijbels, Mathieu Vinken, Peter de Witte, Thomas Bouillon & Pieter Annaert. (2019) Current insights in the complexities underlying drug-induced cholestasis. Critical Reviews in Toxicology 49:6, pages 520-548.
Read now
Read now
Mingxiang Liao, Qing Zhu, Andy Zhu, Christopher Gemski, Bingli Ma, Emily Guan, Albert P. Li, Guangqing Xiao & Cindy Q. Xia. (2019) Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans. Xenobiotica 49:7, pages 852-862.
Read now
Read now
Petar D. Petrov, M. Leonor Fernández-Murga, Mireia López-Riera, M. José Goméz-Lechón, Jose V. Castell & Ramiro Jover. (2018) Predicting drug-induced cholestasis: preclinical models. Expert Opinion on Drug Metabolism & Toxicology 14:7, pages 721-738.
Read now
Read now
Ling Xiao, Yaru Xue, Cuifeng Zhang, Le Wang, Yunfei Lin & Guoyu Pan. (2018) The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of berberine. Xenobiotica 48:3, pages 314-323.
Read now
Read now
Leiyan He, Yaoxue Guo, Ye Deng, Chun Li, Chengzi Zuo & Wenxing Peng. (2017) Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin. Xenobiotica 47:2, pages 154-163.
Read now
Read now
Donna A. Volpe. (2016) Transporter assays as useful in vitro tools in drug discovery and development. Expert Opinion on Drug Discovery 11:1, pages 91-103.
Read now
Read now
Jian Jiang, Jarno EJ Wolters, Simone G van Breda, Jos C Kleinjans & Theo M de Kok. (2015) Development of novel tools for the in vitro investigation of drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 11:10, pages 1523-1537.
Read now
Read now
Yubao Gao, Jiuxing Liang, Yuxi Luo & Yihong Gong. (2015) Structural optimization design of perfusion bioreactors with multilayer circular parallel plates scaffold. Biotechnology & Biotechnological Equipment 29:3, pages 602-608.
Read now
Read now
David A Mann. (2015) Human induced pluripotent stem cell-derived hepatocytes for toxicology testing. Expert Opinion on Drug Metabolism & Toxicology 11:1, pages 1-5.
Read now
Read now
Manuela de Lima Toccafondo Vieira & Carlos Alberto Tagliati. (2014) Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools. Expert Opinion on Drug Metabolism & Toxicology 10:4, pages 581-597.
Read now
Read now
Saeed Alqahtani, Loqman A Mohamed & Amal Kaddoumi. (2013) Experimental models for predicting drug absorption and metabolism. Expert Opinion on Drug Metabolism & Toxicology 9:10, pages 1241-1254.
Read now
Read now
Margaret Clotworthy & Kathy Archibald. (2013) Advances in the development and use of human tissue-based techniques for drug toxicity testing. Expert Opinion on Drug Metabolism & Toxicology 9:9, pages 1155-1169.
Read now
Read now
Eva Ramboer, Tamara Vanhaecke, Vera Rogiers & Mathieu Vinken. (2013) Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters. Drug Metabolism Reviews 45:2, pages 196-217.
Read now
Read now
Tom De Bruyn, Sagnik Chatterjee, Sarinj Fattah, Janneke Keemink, Johan Nicolaï, Patrick Augustijns & Pieter Annaert. (2013) Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity. Expert Opinion on Drug Metabolism & Toxicology 9:5, pages 589-616.
Read now
Read now
Eliane Alexandre, Audrey Baze, Céline Parmentier, Coraline Desbans, Dumrongsak Pekthong, Brigitte Gerin, Claudine Wack, Philippe Bachellier, Bruno Heyd, Jean-Christophe Weber & Lysiane Richert. (2012) Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers. Xenobiotica 42:10, pages 968-979.
Read now
Read now
Tommy B Andersson, Kajsa P Kanebratt & John Gerry Kenna. (2012) The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human. Expert Opinion on Drug Metabolism & Toxicology 8:7, pages 909-920.
Read now
Read now
Adrian Hill, Natalie Mesens, Margino Steemans, Jinghai James Xu & Michael D. Aleo. (2012) Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development. Drug Metabolism Reviews 44:1, pages 127-140.
Read now
Read now
Katherine S. Fenner, Hannah M. Jones, Mohammed Ullah, Sarah Kempshall, Maurice Dickins, Yurong Lai, Paul Morgan & Hugh A. Barton. (2012) The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance. Xenobiotica 42:1, pages 28-45.
Read now
Read now
Jianling Wang & Alan Collis. (2011) Maximizing the outcome of early ADMET models: strategies to win the drug-hunting battles?. Expert Opinion on Drug Metabolism & Toxicology 7:4, pages 381-386.
Read now
Read now
Bruno Stieger & Andreas Geier. (2011) Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. Expert Opinion on Drug Metabolism & Toxicology 7:4, pages 411-425.
Read now
Read now
Articles from other publishers (269)
Mei-Qi Wang, Kai-Hui Zhang, Fang-Le Liu, Rui Zhou, Yun Zeng, A-Li Chen, Yang Yu, Quan Xia, Chen-Chen Zhu & Chao-Zhan Lin. (2024) Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress. Phytomedicine 122, pages 155124.
Crossref
Crossref
Taiji Miyake, Haruka Tsutsui, Manabu Hirabayashi & Tatsuhiko Tachibana. (2023) Quantitative Prediction of OATP-Mediated Disposition and Biliary Clearance Using Human Liver Chimeric Mice. Journal of Pharmacology and Experimental Therapeutics 387:2, pages 135-149.
Crossref
Crossref
Yoko Sakai, Masanari Matsumura, Takahiro Iwao & Tamihide Matsunaga. (2023) Culture methods focusing on bile canalicular formation using primary human hepatocytes in a short time. In Vitro Cellular & Developmental Biology - Animal.
Crossref
Crossref
Hiroshi Arakawa, Yuya Nakazono, Natsumi Matsuoka, Momoka Hayashi, Yoshiyuki Shirasaka, Atsushi Hirao & Ikumi Tamai. (2023) Induction of open-form bile canaliculus formation by hepatocytes for evaluation of biliary drug excretion. Communications Biology 6:1.
Crossref
Crossref
Muluneh M. Fashe, Taryn A. Miner, John K. Fallon, Amanda P. Schauer, Craig Sykes, Philip C. Smith & Craig R. Lee. (2023) Pregnancy related hormones increase CYP3A mediated buprenorphine metabolism in human hepatocytes: a comparison to CYP3A substrates nifedipine and midazolam. Frontiers in Pharmacology 14.
Crossref
Crossref
Ya Gong, Mathieu Danoy, Taketomo Kido, Kento Mitsuhashi, Hyunjin Choi, Tomoaki Matsugi, Jingjing Yang, Katsuhiro Esashika, Jun Takahashi, Masaki Nishikawa, Taichi Ito, Atsushi Miyajima & Yasuyuki Sakai. (2023) Optimization of physical microenvironment to maintain the quiescence of human induced pluripotent stem cell‐derived hepatic stellate cells. Biotechnology and Bioengineering.
Crossref
Crossref
Cheng Chen, Shi-Meng Guo, Yuanjun Sun, He Li, Nan Hu, Kun Yao, Huxin Ni, Zhikan Xia, Bin Xu, Xin Xie & Ya-Qiu Long. (2023) Discovery of orally effective and safe GPR40 agonists by incorporating a chiral, rigid and polar sulfoxide into β-position to the carboxylic acid. European Journal of Medicinal Chemistry 251, pages 115267.
Crossref
Crossref
Yajuan Bi, Xue Wang, Hui Ding, Feng He, Lifeng Han & Youcai Zhang. (2022) Transporter-mediated Natural Product-Drug Interactions. Planta Medica 89:02, pages 119-133.
Crossref
Crossref
Takashi KitaguchiShinichiro Horiuchi, Yukie Kuroda, Katsutoshi OhnoKazuhiro KobayashiMitsuru TanakaSeiichi Ishida. (2023) Construction of extended and functional bile canaliculi using long-term sandwich-cultured cryopreserved human hepatocytes and the application of hepatocytes for predicting the biliary excretion of pharmaceutical and food-related compounds. The Journal of Toxicological Sciences 48:5, pages 251-261.
Crossref
Crossref
Bao Jin, Yitong Liu, Shunda Du, Xinting Sang, Huayu Yang & Yilei Mao. (2022) Current trends and research topics regarding liver 3D bioprinting: A bibliometric analysis research. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Dennis McDuffie, David Barr, Ashutosh Agarwal & Emmanuel Thomas. (2022) Physiologically relevant microsystems to study viral infection in the human liver. Frontiers in Microbiology 13.
Crossref
Crossref
Muluneh M. Fashe, John K. Fallon, Taryn A. Miner, Jacqueline B. Tiley, Philip C. Smith & Craig R. Lee. (2022) Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes. Frontiers in Pharmacology 13.
Crossref
Crossref
Shinichiro Horiuchi, Yukie Kuroda, Ryota Oyafuso, Yuji Komizu, Takashi Takaki, Kazuya Maeda & Seiichi Ishida. (2022) Construction of a culture protocol for functional bile canaliculi formation to apply human iPS cell-derived hepatocytes for cholestasis evaluation. Scientific Reports 12:1.
Crossref
Crossref
Melissa Anne Tutty, Dania Movia & Adriele Prina-Mello. (2022) Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials. Drug Delivery and Translational Research 12:9, pages 2048-2074.
Crossref
Crossref
Ting He, Shida Qiao, Chen Ma, Zhaoliang Peng, Zhitao Wu, Chenhui Ma, Li Han, Qiangqiang Deng, Tianwei Zhang, Yishen Zhu & Guoyu Pan. (2022)
FEK
self‐assembled peptide hydrogels facilitate primary hepatocytes culture and pharmacokinetics screening
. Journal of Biomedical Materials Research Part B: Applied Biomaterials 110:9, pages 2015-2027.
Crossref
Crossref
Flavia Storelli, Cindy Yanfei Li, Madhav Sachar, Vineet Kumar, Scott Heyward, Zsolt Sáfár, Emese Kis & Jashvant D. Unadkat. (2022) Prediction of Hepatobiliary Clearances and Hepatic Concentrations of Transported Drugs in Humans Using Rosuvastatin as a Model Drug. Clinical Pharmacology & Therapeutics 112:3, pages 593-604.
Crossref
Crossref
Chitra Saran, Dong Fu, Henry Ho, Abigail Klein, John K. Fallon, Paavo Honkakoski & Kim L. R. Brouwer. (2022) A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity. Scientific Reports 12:1.
Crossref
Crossref
Dan Li, Qianbo Song, Xiaoyu Ji, Yuanfeng Lyu, Yuen Sze Lai & Zhong Zuo. (2022) 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucopyranoside enhances the hepatotoxicity of emodin in vitro and in vivo. Toxicology Letters 365, pages 74-85.
Crossref
Crossref
Xueming Niu, Mian Lin & Bae Hoon Lee. (2022) An Engineered Protein-Based Building Block (Albumin Methacryloyl) for Fabrication of a 3D In Vitro Cryogel Model. Gels 8:7, pages 404.
Crossref
Crossref
Shu-Wen Teng, Michael Hafey, Jeanine Ballard, Xinjie Lin, Changhong Yun, Vijay More, Robert Houle, Ravi Katwaru, Ann Thomas, Grace Chan, Kim Michel, Yutai Li, Kara Pearson & Christopher Gibson. (2022) Physiologically-based modeling of cholate disposition in beagle dog with and without treatment of the liver transporter inhibitor simeprevir. Computational Toxicology 22, pages 100224.
Crossref
Crossref
Noora Sjöstedt, Jeffry Adiwidjaja, William A. Murphy & Kim L.R. Brouwer. 2022. Drug Transporters. Drug Transporters
257
282
.
Michael W. Gill, Brian J. Murphy, Peter T.W. Cheng, Lakshmi Sivaraman, Myrtle Davis & Lois Lehman-McKeeman. (2022) Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278. Toxicology and Applied Pharmacology 438, pages 115885.
Crossref
Crossref
Katharina S. Nitsche, Iris Müller, Sophie Malcomber, Paul L. Carmichael & Hans Bouwmeester. (2022) Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review. Archives of Toxicology 96:3, pages 711-741.
Crossref
Crossref
Chitra Saran, Louise Sundqvist, Henry Ho, Jonna Niskanen, Paavo Honkakoski & Kim L. R. Brouwer. (2022) Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors. Journal of Pharmacology and Experimental Therapeutics 380:2, pages 114-125.
Crossref
Crossref
Jinping Gan, Brad Bolon, Terry Van Vleet & Charles Wood. 2022. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology
925
966
.
Andrew Baxter. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
627
676
.
L. Ward, J. Wilcock & Philip Butler. 2022. The ADME Encyclopedia. The ADME Encyclopedia
368
379
.
Akinori Takemura & Kousei Ito. 2022. Hepatocytes. Hepatocytes
119
127
.
Dong Fu. 2022. Hepatocytes. Hepatocytes
159
169
.
Zahra Heydari, Ibrahim Zarkesh, Mohammad-Hossein Ghanian, Mahdokht H. Aghdaei, Svetlana Kotova, Ensieh Zahmatkesh, Zahra Farzaneh, Abbas Piryaei, Iman Akbarzadeh, Anastasia Shpichka, Roberto Gramignoli, Peter Timashev, Hossein Baharvand & Massoud Vosough. (2021) Biofabrication of size-controlled liver microtissues incorporated with ECM-derived microparticles to prolong hepatocyte function. Bio-Design and Manufacturing 4:4, pages 790-805.
Crossref
Crossref
Amit Panwar, Prativa Das & Lay Poh Tan. (2021) 3D Hepatic Organoid-Based Advancements in LIVER Tissue Engineering. Bioengineering 8:11, pages 185.
Crossref
Crossref
Janet R. Zhou, Gurnit Kaur, Yingze Ma, Denis Arutyunov, Xiufen Lu, X. Chris Le & Elaine M. Leslie. (2021) Biliary excretion of arsenic by human HepaRG cells is stimulated by selenide and mediated by the multidrug resistance protein 2 (MRP2/ABCC2). Biochemical Pharmacology 193, pages 114799.
Crossref
Crossref
Marlies Oorts, Pieter Van Brantegem, Neel Deferm, Sagnik Chatterjee, Erwin Dreesen, Axelle Cooreman, Mathieu Vinken, Lysiane Richert & Pieter Annaert. (2021) Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics 379:1, pages 20-32.
Crossref
Crossref
Taleah Farasyn, Sonia Pahwa, Chao Xu & Wei Yue. (2021) Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes. European Journal of Pharmaceutical Sciences 165, pages 105951.
Crossref
Crossref
Tze Ker Matthew Leong, Wen Shern Lo, Wei En Zen Lee, Benedict Tan, Xing Zhao Lee, Li Wen Justina Nadia Lee, Jia-Ying Joey Lee, Nivedita Suresh, Lit-Hsin Loo, Evan Szu & Joe Yeong. (2021) Leveraging advances in immunopathology and artificial intelligence to analyze in vitro tumor models in composition and space. Advanced Drug Delivery Reviews 177, pages 113959.
Crossref
Crossref
Kun Du, Shibo Li, Chengpan Li, Ping Li, Chunguang Miao, Tianzhi Luo, Bensheng Qiu & Weiping Ding. (2021) Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply. Acta Biomaterialia 134, pages 228-239.
Crossref
Crossref
William A. Murphy, Chitra Saran, Paavo Honkakoski & Kim L.R. Brouwer. 2021. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity
261
306
.
Janna C. Nawroth, Debora B. Petropolis, Dimitris V. Manatakis, Tengku Ibrahim Maulana, Gabriel Burchett, Katharina Schlünder, Anke Witt, Abhishek Shukla, Konstantia Kodella, Janey Ronxhi, Gauri Kulkarni, Geraldine Hamilton, Ekihiro Seki, Shelly Lu & Katia C. Karalis. (2021) Modeling alcohol-associated liver disease in a human Liver-Chip. Cell Reports 36:3, pages 109393.
Crossref
Crossref
Astia Rizki-Safitri, Fumiya Tokito, Masaki Nishikawa, Minoru Tanaka, Kazuya Maeda, Hiroyuki Kusuhara & Yasuyuki Sakai. (2021) Prospect of in vitro Bile Fluids Collection in Improving Cell-Based Assay of Liver Function. Frontiers in Toxicology 3.
Crossref
Crossref
Dipali Sonawane, Anuradha Reddy, Tarang Jadav, Amit K Sahu, Rakesh K Tekade & Pinaki Sengupta. (2021) Advancements in practical and scientific bioanalytical approaches to metabolism studies in drug development. Bioanalysis 13:11, pages 913-930.
Crossref
Crossref
Andrés Tabernilla, Bruna dos Santos Rodrigues, Alanah Pieters, Anne Caufriez, Kaat Leroy, Raf Van Campenhout, Axelle Cooreman, Ana Rita Gomes, Emma Arnesdotter, Eva Gijbels & Mathieu Vinken. (2021) In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. International Journal of Molecular Sciences 22:9, pages 5038.
Crossref
Crossref
Andrés Rubiano, Amruta Indapurkar, Ryosuke Yokosawa, Alina Miedzik, Barry Rosenzweig, Ayesha Arefin, Chloe M. Moulin, Keri Dame, Neil Hartman, Donna A. Volpe, Murali K. Matta, David J. Hughes, David G. Strauss, Tomasz Kostrzewski & Alexandre J. S. Ribeiro. (2021) Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation. Clinical and Translational Science 14:3, pages 1049-1061.
Crossref
Crossref
Raju Khatri, John K. Fallon, Craig Sykes, Natasha Kulick, Rebecca J. B. Rementer, Taryn A. Miner, Amanda P. Schauer, Angela D. M. Kashuba, Kim A. Boggess, Kim L. R. Brouwer, Philip C. Smith & Craig R. Lee. (2021) Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes. Frontiers in Pharmacology 12.
Crossref
Crossref
Jasleen K. Sodhi & Leslie Z. Benet. (2021) Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization. Journal of Medicinal Chemistry 64:7, pages 3546-3559.
Crossref
Crossref
Rongrong Jiang, Andrew Hart, Laurette Burgess, Dae-Shik Kim, Weidong George Lai & Vaishali Dixit. (2021) Prediction of Transporter-Mediated Drug-Drug Interactions and Phenotyping of Hepatobiliary Transporters Involved in the Clearance of E7766, a Novel Macrocycle-Bridged Dinucleotide. Drug Metabolism and Disposition 49:3, pages 265-275.
Crossref
Crossref
Yixiang Zhong, Jun Sang Yu, Xiaoqiong Wang, Bert Binas & Hye Hyun Yoo. (2021) Chemical‐based primary human hepatocyte monolayer culture for the study of drug metabolism and hepatotoxicity: Comparison with the spheroid model. The FASEB Journal 35:3.
Crossref
Crossref
Ryota Masuzaki, Kevin C. Ray, Joseph Roland, Roy Zent, Youngmin A. Lee & Seth J. Karp. (2021) Integrin β1 Establishes Liver Microstructure and Modulates Transforming Growth Factor β during Liver Development and Regeneration. The American Journal of Pathology 191:2, pages 309-319.
Crossref
Crossref
Muhammad Imran Sohail, Yaprak Dönmez-Cakil, Dániel Szöllősi, Thomas Stockner & Peter Chiba. (2021) The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies. International Journal of Molecular Sciences 22:2, pages 784.
Crossref
Crossref
Dejan AleksićZ.Z., Pavle PetkovićZ.Z., Miloš MilosavljevićN.N., Srđan StefanovicM.M. & Slobodan JankovićM.M.. (2021) Focus group and Delphi process: Stroke and potential drug-drug Interactions (pDDI) in the neurological Intensive Care Unit (NICU). Hospital Pharmacology - International Multidisciplinary Journal 8:2, pages 1041-1050.
Crossref
Crossref
Raju Khatri, Natasha Kulick, Rebecca J.B. Rementer, John K. Fallon, Craig Sykes, Amanda P. Schauer, Melina M. Malinen, Merrie Mosedale, Paul B. Watkins, Angela D.M. Kashuba, Kim A. Boggess, Philip C. Smith, Kim L.R. Brouwer & Craig R. Lee. (2021) Pregnancy-Related Hormones Increase Nifedipine Metabolism in Human Hepatocytes by Inducing CYP3A4 Expression. Journal of Pharmaceutical Sciences 110:1, pages 412-421.
Crossref
Crossref
Shruti Surendran, Pooja Dhurjad & Satheeshkumar Nanjappan. 2021. Evidence Based Validation of Traditional Medicines. Evidence Based Validation of Traditional Medicines
469
494
.
L. Ward, J. Wilcock & P. Butler. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
12
.
Priyanka R. Kulkarni, Amir S. Youssef & Aneesh A. Argikar. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
369
417
.
Chitra Saran, James J. Beaudoin, Nathan D. Pfeifer & Kim L. R. Brouwer. 2021. Quantitative Analysis of Cellular Drug Transport, Disposition, and Delivery. Quantitative Analysis of Cellular Drug Transport, Disposition, and Delivery
97
125
.
Manisha NautiyalCaroline BauchPaul WalkerPaul B. WatkinsMerrie Mosedale. (2020) Fit-For-Purpose Hepatocyte Models Enable the Identification of Early Events Contributing to Idelalisib-Induced Liver Injury. Applied In Vitro Toxicology 6:4, pages 110-119.
Crossref
Crossref
Michael J. Hafey, Robert Houle, Keith Q. Tanis, Ian Knemeyer, Jackie Shang, Qing Chen, Andreas Baudy, James Monroe, Frank D. Sistare & Raymond Evers. (2020) A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery. Drug Metabolism and Disposition 48:11, pages 1147-1160.
Crossref
Crossref
Kenichi Umehara, Carina Cantrill, Matthias Beat Wittwer, Elisa Di Lenarda, Florian Klammers, Aynur Ekiciler, Neil Parrott, Stephen Fowler & Mohammed Ullah. (2020) Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction. Drug Metabolism and Disposition 48:10, pages 849-860.
Crossref
Crossref
Roni F. Kunst, Marije Niemeijer, Luc J.W. van der Laan, Bart Spee & Stan F.J. van de Graaf. (2020) From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease. Biochemical Pharmacology 180, pages 114173.
Crossref
Crossref
Vineet Kumar, Cindy Yanfei Li, Kazuya Ishida, Emese Kis, Zsuzsanna Gáborik & Jashvant D. Unadkat. (2020) Pitfalls in Predicting Hepatobiliary Drug Transport Using Human Sandwich-Cultured Hepatocytes. The AAPS Journal 22:5.
Crossref
Crossref
Mahnaz Maddah, Mohammad A. Mandegar, Keri Dame, Francis Grafton, Kevin Loewke & Alexandre J.S. Ribeiro. (2020) Quantifying drug-induced structural toxicity in hepatocytes and cardiomyocytes derived from hiPSCs using a deep learning method. Journal of Pharmacological and Toxicological Methods 105, pages 106895.
Crossref
Crossref
Ramona Nudischer, Kasper Renggli, Andreas Hierlemann, Adrian B. Roth & Cristina Bertinetti-Lapatki. (2020) Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity. PLOS ONE 15:7, pages e0235745.
Crossref
Crossref
Rajagopal N. Aravalli & Clifford J. Steer. (2020) Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism. Genes 11:7, pages 729.
Crossref
Crossref
Tyler E. Gaston, Donna L. Mendrick, Mary F. Paine, Amy L. Roe & Catherine K. Yeung. (2020) “Natural” is not synonymous with “Safe”: Toxicity of natural products alone and in combination with pharmaceutical agents. Regulatory Toxicology and Pharmacology 113, pages 104642.
Crossref
Crossref
Ho‐Joon Lee, Jiwon Ahn, Cho‐Rock Jung, Yun‐Ji Jeung, Hyun‐Soo Cho, Myung Jin Son & Kyung‐Sook Chung. (2020) Optimization of 3D hydrogel microenvironment for enhanced hepatic functionality of primary human hepatocytes. Biotechnology and Bioengineering 117:6, pages 1864-1876.
Crossref
Crossref
Nidal Ghosheh, Barbara Küppers-Munther, Annika Asplund, Christian X. Andersson, Petter Björquist, Tommy B. Andersson, Helena Carén, Stina Simonsson, Peter Sartipy & Jane Synnergren. (2020) Human Pluripotent Stem Cell-Derived Hepatocytes Show Higher Transcriptional Correlation with Adult Liver Tissue than with Fetal Liver Tissue. ACS Omega 5:10, pages 4816-4827.
Crossref
Crossref
Katsuaki Ito, Noora Sjöstedt & Kim L.R. Brouwer. (2020)
Mechanistic Modeling of the Hepatic Disposition of Estradiol-17
β
-Glucuronide in Sandwich-Cultured Human Hepatocytes
. Drug Metabolism and Disposition 48:2, pages 116-122.
Crossref
Crossref
Richard J. Weaver, Eric A. Blomme, Amy E. Chadwick, Ian M. Copple, Helga H. J. Gerets, Christopher E. Goldring, Andre Guillouzo, Philip G. Hewitt, Magnus Ingelman-Sundberg, Klaus Gjervig Jensen, Satu Juhila, Ursula Klingmüller, Gilles Labbe, Michael J. Liguori, Cerys A. Lovatt, Paul Morgan, Dean J. Naisbitt, Raymond H. H. Pieters, Jan Snoeys, Bob van de Water, Dominic P. Williams & B. Kevin Park. (2019) Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. Nature Reviews Drug Discovery 19:2, pages 131-148.
Crossref
Crossref
Dieter Schrenk, Lan Gao, Ge Lin, Catherine Mahony, Patrick P.J. Mulder, Ad Peijnenburg, Stefan Pfuhler, Ivonne M.C.M. Rietjens, Lukas Rutz, Barbara Steinhoff & Anja These. (2020) Pyrrolizidine alkaloids in food and phytomedicine: Occurrence, exposure, toxicity, mechanisms, and risk assessment - A review. Food and Chemical Toxicology 136, pages 111107.
Crossref
Crossref
Yoshitane Nozaki & Saki Izumi. (2020) Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters. Drug Metabolism and Pharmacokinetics 35:1, pages 56-70.
Crossref
Crossref
Brandy Garzel, Tao Hu, Linhao Li, Yuanfu Lu, Scott Heyward, James Polli, Lei Zhang, Shiew-Mei Huang, Jean-Pierre Raufman & Hongbing Wang. (2020) Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression. Pharmaceutical Research 37:2.
Crossref
Crossref
Zahra Heydari, Mustapha Najimi, Hamed Mirzaei, Anastasia Shpichka, Marc Ruoss, Zahra Farzaneh, Leila Montazeri, Abbas Piryaei, Peter Timashev, Roberto Gramignoli, Andreas Nussler, Hossein Baharvand & Massoud Vosough. (2020) Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies. Cells 9:2, pages 304.
Crossref
Crossref
Akinori Takemura & Kousei Ito. (2020) The trends in predicting drug-induced liver injuryIn vitro肝毒性評価の進歩. Folia Pharmacologica Japonica 155:6, pages 401-405.
Crossref
Crossref
Amanda X. Chen, Arnav Chhabra, Heather E. Fleming & Sangeeta N. Bhatia. 2020. Principles of Tissue Engineering. Principles of Tissue Engineering
737
753
.
Seiichi Ishida. 2020. Organ-on-a-chip. Organ-on-a-chip
181
213
.
Kristen R Ryan, Madelyn C Huang, Stephen S Ferguson, Suramya Waidyanatha, Sreenivasa Ramaiahgari, Julie R Rice, Paul E Dunlap, Scott S Auerbach, Esra Mutlu, Tim Cristy, Jessica Peirfelice, Michael J DeVito, Stephanie L Smith-Roe & Cynthia V Rider. (2019) Evaluating Sufficient Similarity of Botanical Dietary Supplements: Combining Chemical and In Vitro Biological Data. Toxicological Sciences 172:2, pages 316-329.
Crossref
Crossref
Kyung-Jin Jang, Monicah A. Otieno, Janey Ronxhi, Heng-Keang Lim, Lorna Ewart, Konstantia R. Kodella, Debora B. Petropolis, Gauri Kulkarni, Jonathan E. Rubins, David Conegliano, Janna Nawroth, Damir SimicWing Lam, Monica Singer, Erio Barale, Bhanu Singh, Manisha Sonee, Anthony J. Streeter, Carl Manthey, Barry JonesAbhishek SrivastavaLinda C. Andersson, Dominic Williams, Hyoungshin Park, Riccardo Barrile, Josiah Sliz, Anna Herland, Suzzette HaneyKatia KaralisDonald E. Ingber & Geraldine A. Hamilton. (2019) Reproducing human and cross-species drug toxicities using a Liver-Chip. Science Translational Medicine 11:517.
Crossref
Crossref
Jian Jiang, Charlie D. Pieterman, Gökhan Ertaylan, Ralf L. M. Peeters & Theo M. C. M. de Kok. (2019) The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro. Archives of Toxicology 93:11, pages 3067-3098.
Crossref
Crossref
Hee Eun Kang, Melina M. Malinen, Chitra Saran, Paavo Honkakoski & Kim L.R. Brouwer. (2019) Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions. Drug Metabolism and Disposition 47:10, pages 1222-1230.
Crossref
Crossref
Dong Fu, Panli Cardona, Henry Ho, Paul B Watkins & Kim L R Brouwer. (2019) Novel Mechanisms of Valproate Hepatotoxicity: Impaired Mrp2 Trafficking and Hepatocyte Depolarization. Toxicological Sciences 171:2, pages 431-442.
Crossref
Crossref
Zheng Li, Chunxia Liu, Jianyong Yang, Jiaqi Zhou, Zhiwen Ye, Dazhi Feng, Na Yue, Jiayi Tong, Wenlong Huang & Hai Qian. (2019) Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold. European Journal of Medicinal Chemistry 179, pages 608-622.
Crossref
Crossref
Yitian Zhou, Joanne X. Shen & Volker M. Lauschke. (2019) Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury. Frontiers in Pharmacology 10.
Crossref
Crossref
Brandy Garzel, Lei Zhang, Shiew-Mei Huang & Hongbing Wang. (2019) A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis. Current Drug Metabolism 20:8, pages 621-632.
Crossref
Crossref
Cathy Lester, John Troutman, Cindy Obringer, Kenneth Wehmeyer, Peter Stoffolano, Michael Karb, Yan Xu, Amy Roe, Greg Carr, Karen Blackburn & Catherine Mahony. (2019) Intrinsic relative potency of a series of pyrrolizidine alkaloids characterized by rate and extent of metabolism. Food and Chemical Toxicology 131, pages 110523.
Crossref
Crossref
Yoko Sakai, Takahiro Iwao, Takeshi Susukida, Takumi Nukaga, Akinori Takemura, Shuichi Sekine, Kousei Ito & Tamihide Matsunaga. (2019) In vitro bile acid-dependent hepatocyte toxicity assay system using human induced pluripotent stem cell-derived hepatocytes: Current status and disadvantages to overcome. Drug Metabolism and Pharmacokinetics 34:4, pages 264-271.
Crossref
Crossref
Raju Khatri, John K. Fallon, Rebecca J.B. Rementer, Natasha T. Kulick, Craig R. Lee & Philip C. Smith. (2019) Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model. Journal of Pharmacological and Toxicological Methods 98, pages 106590.
Crossref
Crossref
Volker M. Lauschke, Reza Z. Shafagh, Delilah F. G. Hendriks & Magnus Ingelman‐Sundberg. (2019) 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications. Biotechnology Journal 14:7.
Crossref
Crossref
Raúl J. Andrade, Guruprasad P. Aithal, Einar S. Björnsson, Neil Kaplowitz, Gerd A. Kullak-Ublick, Dominique Larrey & Tom H. Karlsen. (2019) EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology 70:6, pages 1222-1261.
Crossref
Crossref
Eva Gijbels, Vânia Vilas-Boas, Neel Deferm, Lindsey Devisscher, Hartmut Jaeschke, Pieter Annaert & Mathieu Vinken. (2019) Mechanisms and in vitro models of drug-induced cholestasis. Archives of Toxicology 93:5, pages 1169-1186.
Crossref
Crossref
Olivier Fardel, Amélie Moreau, Marc Le Vée, Claire Denizot & Yannick Parmentier. (2018) Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes. European Journal of Drug Metabolism and Pharmacokinetics 44:1, pages 13-30.
Crossref
Crossref
Alexander Gleich, Bastian Kaiser, Walther Honscha, Herbert Fuhrmann & Axel Schoeniger. (2019) Evaluation of the hepatocyte-derived cell line BFH12 as an in vitro model for bovine biotransformation. Cytotechnology 71:1, pages 231-244.
Crossref
Crossref
Y Zhang, Y Zhang, J Li, Y Chen, L Han, Q He, J Chu & K Liu. (2018) The role of hepatic antioxidant capacity and hepatobiliary transporter in liver injury induced by isopsoralen in zebrafish larvae. Human & Experimental Toxicology 38:1, pages 36-44.
Crossref
Crossref
Dianlei Wang. 2019. Drug Transporters in Drug Disposition, Effects and Toxicity. Drug Transporters in Drug Disposition, Effects and Toxicity
203
240
.
Pieter Van Brantegem, Neel Deferm, Bing Qi, Tom De Vocht & Pieter Annaert. 2019. Experimental Cholestasis Research. Experimental Cholestasis Research
55
73
.
Eva Gijbels, Tamara Vanhaecke & Mathieu Vinken. 2019. Experimental Cholestasis Research. Experimental Cholestasis Research
325
333
.
Debbie Dewaele, Pieter Annaert & Eef Hoeben. 2019. Experimental Cholestasis Research. Experimental Cholestasis Research
15
23
.
Weijia Han, Qiao Wu, Xiaohui Zhang & Zhongping Duan. (2018) Innovation for hepatotoxicity in vitro research models: A review. Journal of Applied Toxicology 39:1, pages 146-162.
Crossref
Crossref
Varvara Gouliarmou, Alfonso Maria Lostia, Sandra Coecke, Camilla Bernasconi, Jos Bessems, Jean Lou Dorne, Stephen Ferguson, Emanuela Testai, Ursula Gundert Remy, J. Brian Houston, Mario Monshouwer, Andy Nong, Olavi Pelkonen, Siegfried Morath, Barbara A. Wetmore, Andrew Worth, Ugo Zanelli, Maria Chiara Zorzoli & Maurice Whelan. (2018) Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance. Toxicology in Vitro 53, pages 233-244.
Crossref
Crossref
Hiroki Okumura, Anna Nakanishi, Tadahiro Hashita, Takahiro Iwao & Tamihide Matsunaga. (2018) Effect of Celecoxib on Differentiation of Human Induced Pluripotent Stem Cells into Hepatocytes Involves STAT5 Activation. Drug Metabolism and Disposition 46:11, pages 1519-1527.
Crossref
Crossref
J. Gerry Kenna & Jack Uetrecht. (2018) Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk?. Drug Metabolism and Disposition 46:11, pages 1658-1669.
Crossref
Crossref
J. Gerry Kenna, Kunal S. Taskar, Christina Battista, David L. Bourdet, Kim L.R. Brouwer, Kenneth R. Brouwer, David Dai, Christoph Funk, Michael J. Hafey, Yurong Lai, Jonathan Maher, Y. Anne Pak, Jenny M. Pedersen, Joseph W. Polli, A. David Rodrigues, Paul B. Watkins, Kyunghee Yang & Robert W. Yucha. (2018) Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective. Clinical Pharmacology & Therapeutics 104:5, pages 916-932.
Crossref
Crossref
Peng Xu, Hua Zhou, Ya-Zhuo Li, Zhong-Wen Yuan, Chang-Xiao Liu, Liang Liu & Ying Xie. (2018) Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2. Frontiers in Pharmacology 9.
Crossref
Crossref
Céline Parmentier, Delilah F.G. Hendriks, Bruno Heyd, Philippe Bachellier, Magnus Ingelman-Sundberg & Lysiane Richert. (2018) Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent. Toxicology Letters 295, pages 187-194.
Crossref
Crossref
M. Leonor Fernández-Murga, Petar D. Petrov, Isabel Conde, Jose V. Castell, M. José Goméz-Lechón & Ramiro Jover. (2018) Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems. Food and Chemical Toxicology 120, pages 196-212.
Crossref
Crossref
Jonathan P. JacksonKimberly M. FreemanRobert L. St. ClaireIIIIIIChris B. BlackKenneth R. Brouwer. (2018) Cholestatic Drug Induced Liver Injury: A Function of Bile Salt Export Pump Inhibition and Farnesoid X Receptor Antagonism. Applied In Vitro Toxicology 4:3, pages 265-279.
Crossref
Crossref
Bill J. Gurley, Charles R. Yates & John S. Markowitz. (2018) “…Not Intended to Diagnose, Treat, Cure or Prevent Any Disease.” 25 Years of Botanical Dietary Supplement Research and the Lessons Learned. Clinical Pharmacology & Therapeutics 104:3, pages 470-483.
Crossref
Crossref
Natasha R. Catlin, Bradley J. Collins, Scott S. Auerbach, Stephen S. Ferguson, James M. Harnly, Chris Gennings, Suramya Waidyanatha, Glenn E. Rice, Stephanie L. Smith-Roe, Kristine L. Witt & Cynthia V. Rider. (2018) How similar is similar enough? A sufficient similarity case study with Ginkgo biloba extract. Food and Chemical Toxicology 118, pages 328-339.
Crossref
Crossref
Cen Guo, Carl LaCerte, Jeffrey E. Edwards, Kenneth R. Brouwer & Kim L. R. Brouwer. (2018) Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms. Journal of Pharmacology and Experimental Therapeutics 365:2, pages 413-421.
Crossref
Crossref
Jennifer Ryan, Ryan E. Morgan, Yuan Chen, Laurie P. Volak, Robert T. DunnIIII & Kenneth W. Dunn. (2018) Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition. Drug Metabolism and Disposition 46:5, pages 704-718.
Crossref
Crossref
Sarah E Thacker, Manisha Nautiyal, Monicah A Otieno, Paul B Watkins & Merrie Mosedale. (2018) Optimized Methods to Explore the Mechanistic and Biomarker Potential of Hepatocyte-Derived Exosomes in Drug-Induced Liver Injury. Toxicological Sciences 163:1, pages 92-100.
Crossref
Crossref
Marketa Jirouskova, Katerina Nepomucka, Gizem Oyman-Eyrilmez, Alzbeta Kalendova, Helena Havelkova, Lenka Sarnova, Karel Chalupsky, Bjoern Schuster, Oldrich Benada, Petra Miksatkova, Martin Kuchar, Ondrej Fabian, Radislav Sedlacek, Gerhard Wiche & Martin Gregor. (2018) Plectin controls biliary tree architecture and stability in cholestasis. Journal of Hepatology 68:5, pages 1006-1017.
Crossref
Crossref
Yan Zhang, Changyuan Wang, Zhihao Liu, Qiang Meng, Xiaokui Huo, Qi Liu, Pengyuan Sun, Xiaobo Yang, Huijun Sun, Xiaodong Ma & Kexin Liu. (2018) P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats. Pharmacological Reports 70:2, pages 243-250.
Crossref
Crossref
Marlies Oorts, Janneke Keemink, Neel Deferm, Robin Adriaensen, Lysiane Richert, Patrick Augustijns & Pieter Annaert. (2018) Extra collagen overlay prolongs the differentiated phenotype in sandwich-cultured rat hepatocytes. Journal of Pharmacological and Toxicological Methods 90, pages 31-38.
Crossref
Crossref
Shannon M. Bell, Xiaoqing Chang, John F. Wambaugh, David G. Allen, Mike Bartels, Kim L.R. Brouwer, Warren M. Casey, Neepa Choksi, Stephen S. Ferguson, Grazyna Fraczkiewicz, Annie M. Jarabek, Alice Ke, Annie Lumen, Scott G. Lynn, Alicia Paini, Paul S. Price, Caroline Ring, Ted W. Simon, Nisha S. Sipes, Catherine S. Sprankle, Judy Strickland, John Troutman, Barbara A. Wetmore & Nicole C. Kleinstreuer. (2018) In vitro to in vivo extrapolation for high throughput prioritization and decision making. Toxicology in Vitro 47, pages 213-227.
Crossref
Crossref
Komal Ramani, Maria Lauda Tomasi, Joshua Berlind, Nirmala Mavila & Zhaoli Sun. (2018) Role of A-Kinase Anchoring Protein Phosphorylation in Alcohol-Induced Liver Injury and Hepatic Stellate Cell Activation. The American Journal of Pathology 188:3, pages 640-655.
Crossref
Crossref
Zhong-Wen Yuan, Ya-Zhuo Li, Zhong-Qiu Liu, Sen-ling Feng, Hua Zhou, Chang-Xiao Liu, Liang Liu & Ying Xie. (2018) Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies. Pharmacological Research 128, pages 153-166.
Crossref
Crossref
Audrey Burban, Ahmad Sharanek, Christiane Guguen-Guillouzo & André Guillouzo. (2018) Endoplasmic reticulum stress precedes oxidative stress in antibiotic-induced cholestasis and cytotoxicity in human hepatocytes. Free Radical Biology and Medicine 115, pages 166-178.
Crossref
Crossref
Zhixiang Tong, Keir Martyn, Andy Yang, Xiaolei Yin, Benjamin E. Mead, Nitin Joshi, Nicholas E. Sherman, Robert S. Langer & Jeffrey M. Karp. (2018) Towards a defined ECM and small molecule based monolayer culture system for the expansion of mouse and human intestinal stem cells. Biomaterials 154, pages 60-73.
Crossref
Crossref
Chya-Yan Liaw, Shen Ji & Murat Guvendiren. (2018) Engineering 3D Hydrogels for Personalized In Vitro Human Tissue Models. Advanced Healthcare Materials 7:4, pages 1701165.
Crossref
Crossref
Rachelle Prantil-BaunRichard NovakDebarun Das, Mahadevabharath R. Somayaji, Andrzej Przekwas & Donald E. Ingber. (2018) Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips. Annual Review of Pharmacology and Toxicology 58:1, pages 37-64.
Crossref
Crossref
Lorna EwartEva-Maria Dehne, Kristin Fabre, Susan Gibbs, James Hickman, Ellinor Hornberg, Magnus Ingelman-Sundberg, Kyung-Jin Jang, David R. Jones, Volker M. Lauschke, Uwe Marx, Jerome T. Mettetal, Amy PointonDominic WilliamsWolfram-Hubertus Zimmermann & Peter Newham. (2018) Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery. Annual Review of Pharmacology and Toxicology 58:1, pages 65-82.
Crossref
Crossref
Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz & Jashvant D. Unadkat. (2018) Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics. Drug Metabolism and Disposition 46:1, pages 66-74.
Crossref
Crossref
Daniel Kaschek, Ahmad Sharanek, André Guillouzo, Jens Timmer & Richard J Weaver. (2018) A Dynamic Mathematical Model of Bile Acid Clearance in HepaRG Cells. Toxicological Sciences 161:1, pages 48-57.
Crossref
Crossref
E.L. LeCluyse, L.M. Norona, J.A. Akingbasote, L.S. Howell, J.L. Woodhead, M.J. Cross, A.B. Roth & C.E. Goldring. 2018. Comprehensive Toxicology. Comprehensive Toxicology
651
712
.
A. Mak & J. Uetrecht. 2018. Comprehensive Toxicology. Comprehensive Toxicology
681
716
.
Angela Effinger, Caitriona M. O’Driscoll, Mark McAllister & Nikoletta Fotaki. 2018. ADME Processes in Pharmaceutical Sciences. ADME Processes in Pharmaceutical Sciences
301
330
.
Franck A. Atienzar & Jean-Marie Nicolas. 2018. Drug-Induced Liver Toxicity. Drug-Induced Liver Toxicity
125
150
.
Ruitang Deng. 2018. Drug-Induced Liver Toxicity. Drug-Induced Liver Toxicity
301
329
.
Khondoker Alam, Taleah Farasyn, Alexandra Crowe, Kai Ding & Wei Yue. (2017) Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner. PLOS ONE 12:11, pages e0186924.
Crossref
Crossref
Antari Khot, Jay Tibbitts, Dan Rock & Dhaval K. Shah. (2017) Development of a Translational Physiologically Based Pharmacokinetic Model for Antibody-Drug Conjugates: a Case Study with T-DM1. The AAPS Journal 19:6, pages 1715-1734.
Crossref
Crossref
Paul B. Watkins & Merrie Mosedale. 2017. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
774
798
.
Kenneth W. Dunn & Jennifer C. Ryan. (2017) Using quantitative intravital multiphoton microscopy to dissect hepatic transport in rats. Methods 128, pages 40-51.
Crossref
Crossref
Noriko Okudaira. (2017) Evaluation of New Chemical Entities as Substrates of Liver Transporters in the Pharmaceutical Industry: Response to Regulatory Requirements and Future Steps. Journal of Pharmaceutical Sciences 106:9, pages 2251-2256.
Crossref
Crossref
Eiichiro Ogimura, Mayuko Tokizono, Shuichi Sekine, Tetsuya Nakagawa, Kiyoko Bando & Kousei Ito. (2017) Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes. Journal of Pharmaceutical Sciences 106:9, pages 2509-2514.
Crossref
Crossref
Hoa Q. Nguyen, Jian Lin, Emi Kimoto, Ernesto Callegari, Susanna Tse & R. Scott Obach. (2017) Prediction of Losartan-Active Carboxylic Acid Metabolite Exposure Following Losartan Administration Using Static and Physiologically Based Pharmacokinetic Models. Journal of Pharmaceutical Sciences 106:9, pages 2758-2770.
Crossref
Crossref
Julia Riede, Gian Camenisch, Jörg Huwyler & Birk Poller. (2017) Current In Vitro Methods to Determine Hepatic Kp uu : A Comparison of Their Usefulness and Limitations. Journal of Pharmaceutical Sciences 106:9, pages 2805-2814.
Crossref
Crossref
. (2017) Basic Science Liver. Journal of Gastroenterology and Hepatology 32:S2, pages 3-14.
Crossref
Crossref
Eiichiro Ogimura, Tetsuya Nakagawa, Jiro Deguchi, Shuichi Sekine, Kousei Ito & Kiyoko Bando. (2017) Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury. Toxicological Sciences 158:2, pages 347-355.
Crossref
Crossref
Sonia Pahwa, Khondoker Alam, Alexandra Crowe, Taleah Farasyn, Sibylle Neuhoff, Oliver Hatley, Kai Ding & Wei Yue. (2017) Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport. Journal of Pharmaceutical Sciences 106:8, pages 2123-2135.
Crossref
Crossref
Yuanyuan Zhang, Jonathan P. Jackson, Robert L. St. ClaireIIIIII, Kimberly Freeman, Kenneth R. Brouwer & Jeffrey E. Edwards. (2017) Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich-cultured human hepatocytes. Pharmacology Research & Perspectives 5:4, pages e00329.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
309
329
.
Atsushi Kawase, Ryota Hashimoto, Mai Shibata, Hiroaki Shimada & Masahiro Iwaki. (2017) Involvement of Reactive Metabolites of Diclofenac in Cytotoxicity in Sandwich-Cultured Rat Hepatocytes. International Journal of Toxicology 36:3, pages 260-267.
Crossref
Crossref
Cong Liu, Shuichi Sekine, Binbin Song & Kousei Ito. (2017) Use of Primary Rat Hepatocytes for Prediction of Drug‐Induced Mitochondrial Dysfunction. Current Protocols in Toxicology 72:1.
Crossref
Crossref
He Li, Qi Huang, Cheng Chen, Bin Xu, He-Yao Wang & Ya-Qiu Long. (2017) Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold. Journal of Medicinal Chemistry 60:7, pages 2697-2717.
Crossref
Crossref
Mariline Gameiro, Renata Silva, Carolina Rocha-Pereira, Helena Carmo, Félix Carvalho, Maria Bastos & Fernando Remião. (2017) Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP. Molecules 22:4, pages 600.
Crossref
Crossref
Maria Maddalena Angioni, Kevin Bellofatto, Simone Merlin, Silvia Menegon, Andrea Perra, Annalisa Petrelli, Pia Sulas, Silvia Giordano, Amedeo Columbano & Antonia Follenzi. (2017) A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis. Oncotarget 8:9, pages 15716-15731.
Crossref
Crossref
Amin A Banaeiyan, Jannick Theobald, Jurgita Paukštyte, Stefan Wölfl, Caroline B Adiels & Mattias Goksör. (2017) Design and fabrication of a scalable liver-lobule-on-a-chip microphysiological platform. Biofabrication 9:1, pages 015014.
Crossref
Crossref
Anja Zeigerer, Anne Wuttke, Giovanni Marsico, Sarah Seifert, Yannis Kalaidzidis & Marino Zerial. (2017) Functional properties of hepatocytes in vitro are correlated with cell polarity maintenance. Experimental Cell Research 350:1, pages 242-252.
Crossref
Crossref
K. Gupta, Z. Song, H. Tang, E.L.S. Fong, I.C. Ng & H. Yu. 2017. Comprehensive Biomaterials II. Comprehensive Biomaterials II
491
512
.
C. Goldring, R. Weaver, B. Kramer, U. Klingmueller, A. Oppelt, B. Van der Water, J. Commandeur, A. Guillouzo, D. Naisbitt, N. French, N. Kitteringham, C. Pridgeon, P. Knolle, J. Sidaway, R. Sison-Young, L. Kamalian, A. Mercer, L. Faulkner, R. Pieters, M. Ingelman-Sundberg & B. Kevin Park. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
217
238
.
C.M. Hosey & L.Z. Benet. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
102
129
.
Christoph Funk & Adrian Roth. (2016) Current limitations and future opportunities for prediction of DILI from in vitro. Archives of Toxicology 91:1, pages 131-142.
Crossref
Crossref
Volker M. Lauschke, Delilah F. G. Hendriks, Catherine C. Bell, Tommy B. Andersson & Magnus Ingelman-Sundberg. (2016) Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates. Chemical Research in Toxicology 29:12, pages 1936-1955.
Crossref
Crossref
SY Chang, EJ Weber, KP Van Ness, DL Eaton & EJ Kelly. (2016) Liver and Kidney on Chips: Microphysiological Models to Understand Transporter Function. Clinical Pharmacology & Therapeutics 100:5, pages 464-478.
Crossref
Crossref
Sun Woo Sophie Kang, Ghada Haydar, Caitlin Taniane, Geoffrey Farrell, Irwin M. Arias, Jennifer Lippincott-Schwartz & Dong Fu. (2016) AMPK Activation Prevents and Reverses Drug-Induced Mitochondrial and Hepatocyte Injury by Promoting Mitochondrial Fusion and Function. PLOS ONE 11:10, pages e0165638.
Crossref
Crossref
Delilah F. G. Hendriks, Lisa Fredriksson Puigvert, Simon Messner, Wolfgang Mortiz & Magnus Ingelman-Sundberg. (2016) Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Scientific Reports 6:1.
Crossref
Crossref
M. G. Burbank, A. Burban, A. Sharanek, R. J. Weaver, C. Guguen-Guillouzo & A. Guillouzo. (2016) Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis. Drug Metabolism and Disposition 44:11, pages 1780-1793.
Crossref
Crossref
Ayumi Oshikata-Miyazaki & Toshiaki Takezawa. (2015) Development of an oxygenation culture method for activating the liver-specific functions of HepG2 cells utilizing a collagen vitrigel membrane chamber. Cytotechnology 68:5, pages 1801-1811.
Crossref
Crossref
Daniela Deharde, Christin Schneider, Thomas Hiller, Nicolas Fischer, Victoria Kegel, Marc Lübberstedt, Nora Freyer, Jan G. Hengstler, Tommy B. Andersson, Daniel Seehofer, Johann Pratschke, Katrin Zeilinger & Georg Damm. (2016) Bile canaliculi formation and biliary transport in 3D sandwich-cultured hepatocytes in dependence of the extracellular matrix composition. Archives of Toxicology 90:10, pages 2497-2511.
Crossref
Crossref
Akinori Takemura, Aya Izaki, Shuichi Sekine & Kousei Ito. (2016) Inhibition of bile canalicular network formation in rat sandwich cultured hepatocytes by drugs associated with risk of severe liver injury. Toxicology in Vitro 35, pages 121-130.
Crossref
Crossref
Yaofeng Cheng, Thomas F. Woolf, Jinping Gan & Kan He. (2016) In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review. Chemico-Biological Interactions 255, pages 23-30.
Crossref
Crossref
C. Guo, K. Yang, K. R. Brouwer, R. L. St. Claire & K. L. R. Brouwer. (2016) Prediction of Altered Bile Acid Disposition Due to Inhibition of Multiple Transporters: An Integrated Approach Using Sandwich-Cultured Hepatocytes, Mechanistic Modeling, and Simulation. Journal of Pharmacology and Experimental Therapeutics 358:2, pages 324-333.
Crossref
Crossref
T. Bohnert, A. Patel, I. Templeton, Y. Chen, C. Lu, G. Lai, L. Leung, S. Tse, H. J. Einolf, Y.-H. Wang, M. Sinz, R. Stearns, R. Walsky, W. Geng, S. Sudsakorn, D. Moore, L. He, J. Wahlstrom, J. Keirns, R. Narayanan, D. Lang & X. Yang. (2016) Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions--an Industry Perspective. Drug Metabolism and Disposition 44:8, pages 1399-1423.
Crossref
Crossref
Irina Kalashnikova, Norah Albekairi, Shariq Ali, Sanaalarab Al Enazy & Erik Rytting. 2016. Drug Delivery. Drug Delivery
131
151
.
Y. Lu, J. R. Slizgi, K. R. Brouwer, R. L. St. Claire, K. M. Freeman, M. Pan, W. J. Brock & K. L. R. Brouwer. (2016) Hepatocellular Disposition and Transporter Interactions with Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes. Drug Metabolism and Disposition 44:6, pages 867-870.
Crossref
Crossref
Jialin Mao, Suzanne Tay, Cyrus S. Khojasteh, Yuan Chen, Cornelis E. C. A. Hop & Jane R. Kenny. (2016) Evaluation of Time Dependent Inhibition Assays for Marketed Oncology Drugs: Comparison of Human Hepatocytes and Liver Microsomes in the Presence and Absence of Human Plasma. Pharmaceutical Research 33:5, pages 1204-1219.
Crossref
Crossref
J. Gerry Kenna, Mikael Persson, Scott Q. Siler, Ke Yu, Chuchu Hu, Minjun Chen, Joshua Xu, Weida Tong, Yvonne Will & Michael D. Aleo. 2016. Drug Discovery Toxicology. Drug Discovery Toxicology
93
129
.
Amy L. Roe, Mary F. Paine, Bill J. Gurley, Kenneth R. Brouwer, Scott Jordan & James C. Griffiths. (2016) Assessing Natural Product?Drug Interactions: An End-to-End Safety Framework. Regulatory Toxicology and Pharmacology 76, pages 1-6.
Crossref
Crossref
Takeshi Susukida, Shuichi Sekine, Mayuka Nozaki, Mayuko Tokizono, Kumiko Oizumi, Toshiharu Horie & Kousei Ito. (2016) Establishment of a Drug-Induced, Bile Acid?Dependent Hepatotoxicity Model Using HepaRG Cells. Journal of Pharmaceutical Sciences 105:4, pages 1550-1560.
Crossref
Crossref
Khondoker Alam, Sonia Pahwa, Xueying Wang, Pengyue Zhang, Kai Ding, Alaa H. Abuznait, Lang Li & Wei Yue. (2016) Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions. Molecular Pharmaceutics 13:3, pages 839-851.
Crossref
Crossref
Lei-lei Ma, Zhi-tao Wu, Le Wang, Xue-feng Zhang, Jing Wang, Chen Chen, Xuan Ni, Yun-fei Lin, Yi-yi Cao, Yang Luan & Guo-yu Pan. (2016) Inhibition of hepatic cytochrome P450 enzymes and sodium/bile acid cotransporter exacerbates leflunomide-induced hepatotoxicity. Acta Pharmacologica Sinica 37:3, pages 415-424.
Crossref
Crossref
Ewart W. Kuijk, Shauna Rasmussen, Francis Blokzijl, Meritxell Huch, Helmuth Gehart, Pim Toonen, Harry Begthel, Hans Clevers, Aron M. Geurts & Edwin Cuppen. (2016) Generation and characterization of rat liver stem cell lines and their engraftment in a rat model of liver failure. Scientific Reports 6:1.
Crossref
Crossref
Saki Izumi, Yoshitane Nozaki, Takafumi Komori, Osamu Takenaka, Kazuya Maeda, Hiroyuki Kusuhara & Yuichi Sugiyama. (2016) Investigation of Fluorescein Derivatives as Substrates of Organic Anion Transporting Polypeptide (OATP) 1B1 To Develop Sensitive Fluorescence-Based OATP1B1 Inhibition Assays. Molecular Pharmaceutics 13:2, pages 438-448.
Crossref
Crossref
Kyunghee Yang, Cen Guo, Jeffrey L. Woodhead, Robert L. St. ClaireIIIIII, Paul B. Watkins, Scott Q. Siler, Brett A. Howell & Kim L.R. Brouwer. (2016) Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury. Journal of Pharmaceutical Sciences 105:2, pages 443-459.
Crossref
Crossref
Tom De Bruyn, Patrick F. Augustijns & Pieter P. Annaert. (2016) Hepatic Clearance Prediction of Nine Human Immunodeficiency Virus Protease Inhibitors in Rat. Journal of Pharmaceutical Sciences 105:2, pages 846-853.
Crossref
Crossref
Franck A. Atienzar, Eric A. Blomme, Minjun Chen, Philip Hewitt, J. Gerry Kenna, Gilles Labbe, Frederic Moulin, Francois Pognan, Adrian B. Roth, Laura Suter-Dick, Okechukwu Ukairo, Richard J. Weaver, Yvonne Will & Donna M. Dambach. (2016) Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans. BioMed Research International 2016, pages 1-20.
Crossref
Crossref
Jason R. Slizgi, Yang Lu, Kenneth R. Brouwer, Robert L. St. Claire, Kimberly M. Freeman, Maxwell Pan, William J. Brock & Kim L. R. Brouwer. (2016) Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?. Toxicological Sciences 149:1, pages 237-250.
Crossref
Crossref
Displaying 200 of 293 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list